Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + Letrozole Access Study in Latin America
NCT02600923Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by Pfizer. Started Apr 2016; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02600923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600923.